newest glp-1 drugs New Guidelines for Type 2 Diabetes in 2025 The number of Americans taking

Frontiers, Gofron, Krzysztof Ksawery, et al

Mounjaro highlights of prescribing information, Food and Drug Administration (2024) Farxiga highlights of prescribing information, Food and Drug Administration (2024) Oral & injectable medications for type 2 diabetes, American Diabetes Association Similar effectiveness of dapagliflozin and GLP1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study, Diabetes, Obesity and Metabolism (2019) Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis, BMC Endocrine Disorders (2024) Sodium-glucose transport protein 2 (SGLT2) inhibitors, StatPearls (2023) Tirzepatide injection, MedlinePlus (2025) Acute kidney injury (AKI), National Kidney Foundation (2024) FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes, Food and Drug Administration (2018) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

? May reduce appetite : While not as strong as GLP-1s, berberine may mildly reduce hunger, helping reinforce your efforts

GEM Project Research Consortium